Literature DB >> 11283117

Chronic melioidosis in a patient with cystic fibrosis.

T Schülin1, I Steinmetz.   

Abstract

Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and northern Australia, where it can be found in soil and surface water. We report a case of chronic pulmonary melioidosis in a patient with cystic fibrosis who had traveled to an area where B. pseudomallei is endemic.

Entities:  

Mesh：

Year:  2001        PMID： 11283117      PMCID： PMC88000          DOI： 10.1128/JCM.39.4.1676-1677.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Neck lumps: expect the unexpected.

Authors:  A M Kärcher; A Zaman; C Brewis; T Fahmy
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

2.  Combination antibiotic therapy for severe melioidosis.

Authors:  A J Simpson; N J White
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

3.  Brain abscess as the presenting feature of melioidosis.

Authors:  R Lath; V Rajshekhar; V George
Journal:  Br J Neurosurg       Date:  1998-04       Impact factor: 1.596

4.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 5.  Burkholderia cepacia. Management issues and new insights.

Authors:  J J LiPuma
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

6.  Imported melioidosis in England and Wales.

Authors:  D A Dance; M D Smith; H M Aucken; T L Pitt
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

7.  Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

Authors:  D A Dance; V Wuthiekanun; P Naigowit; N J White
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

8.  Comparison of imipenem and ceftazidime as therapy for severe melioidosis.

Authors:  A J Simpson; Y Suputtamongkol; M D Smith; B J Angus; A Rajanuwong; V Wuthiekanun; P A Howe; A L Walsh; W Chaowagul; N J White
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

9.  Potential misidentification of Burkholderia pseudomallei by API 20NE.

Authors:  T J Inglis; D Chiang; G S Lee; L Chor-Kiang
Journal:  Pathology       Date:  1998-02       Impact factor: 5.306

10.  Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody.

Authors:  I Steinmetz; A Reganzerowski; B Brenneke; S Haussler; A Simpson; N J White
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948
View more
  18 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 6.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

7.  Outcomes of patients with melioidosis treated with meropenem.

Authors:  Allen C Cheng; Dale A Fisher; Nicholas M Anstey; Dianne P Stephens; Susan P Jacups; Bart J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.

Authors:  A R Brown; J R W Govan
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

9.  Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil.

Authors:  Afonso Luís Barth; Fernando Antonio de Abreu E Silva; Anneliese Hoffmann; Maria Izolete Vieira; Alexandre Prehn Zavascki; Alex Guerra Ferreira; Luiz Gonzaga da Cunha; Rodolpho Mattos Albano; Elizabeth de Andrade Marques
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

10.  Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Authors:  Dimas Mateos Corral; Allan L Coates; Yvonne C W Yau; Raymond Tellier; Mindy Glass; Steven M Jones; Valerie J Waters
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.